Total raised
$56K
Stage
Pre-Funding
Founded
2011
Headcount
6
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
LipoMedix Pharmaceuticals is a privately held development-stage company focused on an innovative, safe, and effective cancer therapy based on liposome delivery. The companys lead product, Promitil, has demonstrated antitumor effects in tumor models that rival or outperform the effects of many standard forms of chemotherapy, such as cisplatin, irinotecan, gemcitabine, and doxorubicin, with less toxicity.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
canceroncologybiopharmaceuticaldrug-deliverytargeted-therapychemotherapytherapeuticspharmaceuticalspharma-companies